Standard BioTools Inc.
LAB
$1.07
-$0.045-4.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 169.69M | 174.43M | 155.90M | 136.30M | 126.76M |
| Total Other Revenue | -- | 921.00K | 921.00K | 921.00K | 1.10M |
| Total Revenue | 169.69M | 174.43M | 155.90M | 136.30M | 126.76M |
| Cost of Revenue | 109.09M | 109.39M | 99.41M | 91.92M | 70.64M |
| Gross Profit | 60.59M | 65.04M | 56.49M | 44.39M | 56.12M |
| SG&A Expenses | 146.47M | 154.71M | 138.47M | 126.36M | 113.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 294.10M | 307.29M | 273.93M | 247.54M | 213.09M |
| Operating Income | -124.42M | -132.86M | -118.03M | -111.24M | -86.33M |
| Income Before Tax | -132.47M | -138.31M | -124.45M | -118.58M | -89.65M |
| Income Tax Expenses | 294.00K | 573.00K | 139.00K | 71.00K | 317.00K |
| Earnings from Continuing Operations | -132.76 | -138.89 | -124.59 | -118.65 | -89.97 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -132.76M | -138.89M | -124.59M | -118.65M | -89.97M |
| EBIT | -124.42M | -132.86M | -118.03M | -111.24M | -86.33M |
| EBITDA | -105.52M | -112.94M | -98.16M | -88.15M | -66.82M |
| EPS Basic | -0.36 | -0.55 | -0.71 | -0.90 | -1.00 |
| Normalized Basic EPS | -0.18 | -0.22 | -0.27 | -0.38 | -0.43 |
| EPS Diluted | -0.36 | -0.55 | -0.71 | -0.91 | -1.01 |
| Normalized Diluted EPS | -0.18 | -0.22 | -0.27 | -0.38 | -0.43 |
| Average Basic Shares Outstanding | 1.50B | 1.41B | 1.12B | 825.34M | 531.68M |
| Average Diluted Shares Outstanding | 1.50B | 1.41B | 1.12B | 825.34M | 531.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |